GlassScriptPhysician profile
Desiree Simpson Grant
NPI 1477908515
$4,628.18
in general payments reported to CMS, 2019-2025
11 companies · $3,028 in 2025
The $3,028 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.17 · 2024: $1,546 · 2025: $3,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,596 · Education: $1,500 · Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,596.18 |
| Education | $1,500.00 |
| Food and Beverage | $477.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,157.41 | 2024-2025 | |
| Abbvie INC. | $262.19 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $39.40 | 2025 | Gemtesa |
| Biogen, INC. | $29.57 | 2025 | Zurzuvae |
| Organon LLC | $24.93 | 2024 | |
| Astellas Pharma US INC | $23.17 | 2024 | Veozah |
| Minerva Surgical, INC | $21.16 | 2025 | |
| Mayne Pharma Commercial LLC | $20.68 | 2021 | |
| Meditrina | $19.56 | 2025 | |
| Pfizer INC. | $15.82 | 2025 | |
| Avion Pharmaceuticals | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Simpson Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.